Projects funded by the NCN
Rola receptora GPR39 w zaburzeniach drgawkowych
2016/20/S/NZ7/00424
Keywords:
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: FUGA 5 - announced on 2015-12-15
Amount awarded: 612 000 PLN
Project start date (Y-m-d): 2016-12-01
Project end date (Y-m-d): 2019-11-30
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Articles in post-conference publications (1)
- Zinc signaling and epilepsyAuthors:Doboszewska U, Młyniec K, Wlaź A, Poleszak E, Nowak G, Wlaź PAcademic press:Pharmacology & Therapeutics (rok: 2019, tom: 193, strony: 156-177), Wydawca: Elsevier Inc.Status:PublishedDOI:10.1016/j.pharmthera.2018.08.013 - link to the publication
- TC-G 1008, GPR39 (zinc receptor) agonist decreases seizure threshold in maximal electroshock seizure threshold test and facilitates kindling development in pentylenetrazole kindling model in miceAuthors:Doboszewska Urszula, Socała Katarzyna, Pieróg Mateusz, Nieoczym Dorota, Wyska Elżbieta, Wlaź PiotrConference:4th Congress of the European Academy of Neurology (rok: 2018, ), Wydawca: European Journal of Neurology, Wiley Online LibraryData:konferencja 16-19.06.2018Status:Published